MITF and melanoma: The expression of AXL is inversely related to that of MITF, so that MITFhigh/AXLlow (proliferative) and MITFlow/AXLhigh (invasive) populations contribute mostly to intratumor heterogeneity in melanoma and, thereby, resistance to therapy [55].